nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—NT5E—Cytarabine—lymphatic system cancer	0.865	0.968	CbGbCtD
Pentoxifylline—CYP1A2—Carmustine—lymphatic system cancer	0.0285	0.0319	CbGbCtD
Pentoxifylline—Infection—Fludarabine—lymphatic system cancer	0.00041	0.00384	CcSEcCtD
Pentoxifylline—Decreased appetite—Teniposide—lymphatic system cancer	0.000408	0.00383	CcSEcCtD
Pentoxifylline—Vomiting—Mechlorethamine—lymphatic system cancer	0.000405	0.0038	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.000404	0.00379	CcSEcCtD
Pentoxifylline—Rash—Mechlorethamine—lymphatic system cancer	0.000401	0.00376	CcSEcCtD
Pentoxifylline—Dermatitis—Mechlorethamine—lymphatic system cancer	0.000401	0.00376	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.000399	0.00374	CcSEcCtD
Pentoxifylline—Flushing—Bleomycin—lymphatic system cancer	0.000395	0.0037	CcSEcCtD
Pentoxifylline—Anorexia—Fludarabine—lymphatic system cancer	0.000393	0.00369	CcSEcCtD
Pentoxifylline—Feeling abnormal—Teniposide—lymphatic system cancer	0.000387	0.00363	CcSEcCtD
Pentoxifylline—Drowsiness—Mitoxantrone—lymphatic system cancer	0.000385	0.00361	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.000384	0.0036	CcSEcCtD
Pentoxifylline—Sweating—Vincristine—lymphatic system cancer	0.000379	0.00355	CcSEcCtD
Pentoxifylline—Nausea—Mechlorethamine—lymphatic system cancer	0.000378	0.00355	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.000376	0.00352	CcSEcCtD
Pentoxifylline—Jaundice—Mitoxantrone—lymphatic system cancer	0.000375	0.00352	CcSEcCtD
Pentoxifylline—Conjunctivitis—Mitoxantrone—lymphatic system cancer	0.000374	0.00351	CcSEcCtD
Pentoxifylline—Haemoglobin—Carmustine—lymphatic system cancer	0.000374	0.0035	CcSEcCtD
Pentoxifylline—Urticaria—Teniposide—lymphatic system cancer	0.000373	0.0035	CcSEcCtD
Pentoxifylline—Haemorrhage—Carmustine—lymphatic system cancer	0.000372	0.00348	CcSEcCtD
Pentoxifylline—Abdominal pain—Teniposide—lymphatic system cancer	0.000371	0.00348	CcSEcCtD
Pentoxifylline—Body temperature increased—Teniposide—lymphatic system cancer	0.000371	0.00348	CcSEcCtD
Pentoxifylline—Erythema—Bleomycin—lymphatic system cancer	0.000371	0.00347	CcSEcCtD
Pentoxifylline—Sweating—Mitoxantrone—lymphatic system cancer	0.000369	0.00346	CcSEcCtD
Pentoxifylline—Dyspnoea—Fludarabine—lymphatic system cancer	0.000368	0.00345	CcSEcCtD
Pentoxifylline—Dyspepsia—Fludarabine—lymphatic system cancer	0.000363	0.0034	CcSEcCtD
Pentoxifylline—Decreased appetite—Fludarabine—lymphatic system cancer	0.000359	0.00336	CcSEcCtD
Pentoxifylline—Constipation—Fludarabine—lymphatic system cancer	0.000353	0.00331	CcSEcCtD
Pentoxifylline—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.000347	0.00326	CcSEcCtD
Pentoxifylline—Hypersensitivity—Teniposide—lymphatic system cancer	0.000346	0.00324	CcSEcCtD
Pentoxifylline—Hepatitis—Mitoxantrone—lymphatic system cancer	0.000345	0.00324	CcSEcCtD
Pentoxifylline—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.000345	0.00324	CcSEcCtD
Pentoxifylline—Flushing—Carmustine—lymphatic system cancer	0.000345	0.00323	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.000344	0.00322	CcSEcCtD
Pentoxifylline—Anaemia—Bleomycin—lymphatic system cancer	0.000343	0.00321	CcSEcCtD
Pentoxifylline—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00034	0.00319	CcSEcCtD
Pentoxifylline—Asthenia—Teniposide—lymphatic system cancer	0.000337	0.00316	CcSEcCtD
Pentoxifylline—Malaise—Bleomycin—lymphatic system cancer	0.000334	0.00313	CcSEcCtD
Pentoxifylline—Pruritus—Teniposide—lymphatic system cancer	0.000332	0.00311	CcSEcCtD
Pentoxifylline—Arrhythmia—Carmustine—lymphatic system cancer	0.000332	0.00311	CcSEcCtD
Pentoxifylline—Leukopenia—Bleomycin—lymphatic system cancer	0.000332	0.00311	CcSEcCtD
Pentoxifylline—Body temperature increased—Fludarabine—lymphatic system cancer	0.000326	0.00306	CcSEcCtD
Pentoxifylline—Erythema—Carmustine—lymphatic system cancer	0.000324	0.00303	CcSEcCtD
Pentoxifylline—Aplastic anaemia—Methotrexate—lymphatic system cancer	0.000322	0.00302	CcSEcCtD
Pentoxifylline—Diarrhoea—Teniposide—lymphatic system cancer	0.000321	0.00301	CcSEcCtD
Pentoxifylline—Chest pain—Bleomycin—lymphatic system cancer	0.000316	0.00296	CcSEcCtD
Pentoxifylline—Myalgia—Bleomycin—lymphatic system cancer	0.000316	0.00296	CcSEcCtD
Pentoxifylline—Back pain—Carmustine—lymphatic system cancer	0.000313	0.00293	CcSEcCtD
Pentoxifylline—Discomfort—Bleomycin—lymphatic system cancer	0.000312	0.00292	CcSEcCtD
Pentoxifylline—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.000309	0.00289	CcSEcCtD
Pentoxifylline—Confusional state—Bleomycin—lymphatic system cancer	0.000305	0.00286	CcSEcCtD
Pentoxifylline—Vision blurred—Carmustine—lymphatic system cancer	0.000305	0.00286	CcSEcCtD
Pentoxifylline—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000304	0.00285	CcSEcCtD
Pentoxifylline—Tremor—Carmustine—lymphatic system cancer	0.000303	0.00284	CcSEcCtD
Pentoxifylline—Oedema—Bleomycin—lymphatic system cancer	0.000302	0.00284	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000302	0.00284	CcSEcCtD
Pentoxifylline—Erythema—Mitoxantrone—lymphatic system cancer	0.000301	0.00282	CcSEcCtD
Pentoxifylline—Infection—Bleomycin—lymphatic system cancer	0.000301	0.00282	CcSEcCtD
Pentoxifylline—Anaemia—Carmustine—lymphatic system cancer	0.000299	0.0028	CcSEcCtD
Pentoxifylline—Back pain—Vincristine—lymphatic system cancer	0.000299	0.0028	CcSEcCtD
Pentoxifylline—Vomiting—Teniposide—lymphatic system cancer	0.000298	0.0028	CcSEcCtD
Pentoxifylline—Agitation—Carmustine—lymphatic system cancer	0.000297	0.00279	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000296	0.00278	CcSEcCtD
Pentoxifylline—Asthenia—Fludarabine—lymphatic system cancer	0.000296	0.00277	CcSEcCtD
Pentoxifylline—Rash—Teniposide—lymphatic system cancer	0.000296	0.00277	CcSEcCtD
Pentoxifylline—Dermatitis—Teniposide—lymphatic system cancer	0.000296	0.00277	CcSEcCtD
Pentoxifylline—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000295	0.00276	CcSEcCtD
Pentoxifylline—Headache—Teniposide—lymphatic system cancer	0.000294	0.00276	CcSEcCtD
Pentoxifylline—Pruritus—Fludarabine—lymphatic system cancer	0.000292	0.00274	CcSEcCtD
Pentoxifylline—Back pain—Mitoxantrone—lymphatic system cancer	0.000291	0.00273	CcSEcCtD
Pentoxifylline—Leukopenia—Carmustine—lymphatic system cancer	0.00029	0.00271	CcSEcCtD
Pentoxifylline—Anorexia—Bleomycin—lymphatic system cancer	0.000288	0.0027	CcSEcCtD
Pentoxifylline—Anaemia—Vincristine—lymphatic system cancer	0.000285	0.00268	CcSEcCtD
Pentoxifylline—Agitation—Vincristine—lymphatic system cancer	0.000284	0.00266	CcSEcCtD
Pentoxifylline—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000283	0.00266	CcSEcCtD
Pentoxifylline—Hypotension—Bleomycin—lymphatic system cancer	0.000283	0.00265	CcSEcCtD
Pentoxifylline—Diarrhoea—Fludarabine—lymphatic system cancer	0.000282	0.00265	CcSEcCtD
Pentoxifylline—Convulsion—Carmustine—lymphatic system cancer	0.00028	0.00263	CcSEcCtD
Pentoxifylline—Hypertension—Carmustine—lymphatic system cancer	0.000279	0.00262	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000279	0.00262	CcSEcCtD
Pentoxifylline—Nausea—Teniposide—lymphatic system cancer	0.000279	0.00261	CcSEcCtD
Pentoxifylline—Anaemia—Mitoxantrone—lymphatic system cancer	0.000278	0.00261	CcSEcCtD
Pentoxifylline—Leukopenia—Vincristine—lymphatic system cancer	0.000276	0.00259	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000276	0.00258	CcSEcCtD
Pentoxifylline—Chest pain—Carmustine—lymphatic system cancer	0.000275	0.00258	CcSEcCtD
Pentoxifylline—Myalgia—Carmustine—lymphatic system cancer	0.000275	0.00258	CcSEcCtD
Pentoxifylline—Anxiety—Carmustine—lymphatic system cancer	0.000274	0.00257	CcSEcCtD
Pentoxifylline—Malaise—Mitoxantrone—lymphatic system cancer	0.000271	0.00254	CcSEcCtD
Pentoxifylline—Dyspnoea—Bleomycin—lymphatic system cancer	0.00027	0.00253	CcSEcCtD
Pentoxifylline—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000269	0.00252	CcSEcCtD
Pentoxifylline—Convulsion—Vincristine—lymphatic system cancer	0.000268	0.00251	CcSEcCtD
Pentoxifylline—Hypertension—Vincristine—lymphatic system cancer	0.000267	0.0025	CcSEcCtD
Pentoxifylline—Confusional state—Carmustine—lymphatic system cancer	0.000266	0.0025	CcSEcCtD
Pentoxifylline—Oedema—Carmustine—lymphatic system cancer	0.000264	0.00248	CcSEcCtD
Pentoxifylline—Decreased appetite—Bleomycin—lymphatic system cancer	0.000263	0.00247	CcSEcCtD
Pentoxifylline—Myalgia—Vincristine—lymphatic system cancer	0.000263	0.00246	CcSEcCtD
Pentoxifylline—Infection—Carmustine—lymphatic system cancer	0.000262	0.00246	CcSEcCtD
Pentoxifylline—Vomiting—Fludarabine—lymphatic system cancer	0.000262	0.00246	CcSEcCtD
Pentoxifylline—Convulsion—Mitoxantrone—lymphatic system cancer	0.000261	0.00244	CcSEcCtD
Pentoxifylline—Rash—Fludarabine—lymphatic system cancer	0.00026	0.00244	CcSEcCtD
Pentoxifylline—Dermatitis—Fludarabine—lymphatic system cancer	0.00026	0.00244	CcSEcCtD
Pentoxifylline—Hypertension—Mitoxantrone—lymphatic system cancer	0.00026	0.00243	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000259	0.00242	CcSEcCtD
Pentoxifylline—Headache—Fludarabine—lymphatic system cancer	0.000258	0.00242	CcSEcCtD
Pentoxifylline—Tachycardia—Carmustine—lymphatic system cancer	0.000258	0.00242	CcSEcCtD
Pentoxifylline—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.000257	0.00241	CcSEcCtD
Pentoxifylline—Chest pain—Mitoxantrone—lymphatic system cancer	0.000256	0.0024	CcSEcCtD
Pentoxifylline—Myalgia—Mitoxantrone—lymphatic system cancer	0.000256	0.0024	CcSEcCtD
Pentoxifylline—Anxiety—Mitoxantrone—lymphatic system cancer	0.000255	0.00239	CcSEcCtD
Pentoxifylline—Discomfort—Mitoxantrone—lymphatic system cancer	0.000253	0.00237	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000252	0.00236	CcSEcCtD
Pentoxifylline—Oedema—Vincristine—lymphatic system cancer	0.000252	0.00236	CcSEcCtD
Pentoxifylline—Anorexia—Carmustine—lymphatic system cancer	0.000252	0.00236	CcSEcCtD
Pentoxifylline—Infection—Vincristine—lymphatic system cancer	0.00025	0.00235	CcSEcCtD
Pentoxifylline—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000249	0.00234	CcSEcCtD
Pentoxifylline—Confusional state—Mitoxantrone—lymphatic system cancer	0.000247	0.00232	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000247	0.00231	CcSEcCtD
Pentoxifylline—Hypotension—Carmustine—lymphatic system cancer	0.000247	0.00231	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000245	0.0023	CcSEcCtD
Pentoxifylline—Oedema—Mitoxantrone—lymphatic system cancer	0.000245	0.0023	CcSEcCtD
Pentoxifylline—Nausea—Fludarabine—lymphatic system cancer	0.000245	0.0023	CcSEcCtD
Pentoxifylline—Infection—Mitoxantrone—lymphatic system cancer	0.000244	0.00229	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000244	0.00228	CcSEcCtD
Pentoxifylline—Shock—Mitoxantrone—lymphatic system cancer	0.000241	0.00226	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000241	0.00226	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00024	0.00225	CcSEcCtD
Pentoxifylline—Urticaria—Bleomycin—lymphatic system cancer	0.00024	0.00225	CcSEcCtD
Pentoxifylline—Anorexia—Vincristine—lymphatic system cancer	0.00024	0.00225	CcSEcCtD
Pentoxifylline—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00024	0.00225	CcSEcCtD
Pentoxifylline—Body temperature increased—Bleomycin—lymphatic system cancer	0.000239	0.00224	CcSEcCtD
Pentoxifylline—Insomnia—Carmustine—lymphatic system cancer	0.000239	0.00224	CcSEcCtD
Pentoxifylline—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000238	0.00224	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000237	0.00222	CcSEcCtD
Pentoxifylline—Hypotension—Vincristine—lymphatic system cancer	0.000236	0.00221	CcSEcCtD
Pentoxifylline—Dyspnoea—Carmustine—lymphatic system cancer	0.000235	0.00221	CcSEcCtD
Pentoxifylline—Somnolence—Carmustine—lymphatic system cancer	0.000235	0.0022	CcSEcCtD
Pentoxifylline—Anorexia—Mitoxantrone—lymphatic system cancer	0.000234	0.00219	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00023	0.00215	CcSEcCtD
Pentoxifylline—Decreased appetite—Carmustine—lymphatic system cancer	0.00023	0.00215	CcSEcCtD
Pentoxifylline—Hypotension—Mitoxantrone—lymphatic system cancer	0.000229	0.00215	CcSEcCtD
Pentoxifylline—Insomnia—Vincristine—lymphatic system cancer	0.000228	0.00214	CcSEcCtD
Pentoxifylline—Constipation—Carmustine—lymphatic system cancer	0.000226	0.00212	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000224	0.0021	CcSEcCtD
Pentoxifylline—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000223	0.00209	CcSEcCtD
Pentoxifylline—Decreased appetite—Vincristine—lymphatic system cancer	0.000219	0.00205	CcSEcCtD
Pentoxifylline—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000219	0.00205	CcSEcCtD
Pentoxifylline—Somnolence—Mitoxantrone—lymphatic system cancer	0.000218	0.00205	CcSEcCtD
Pentoxifylline—Feeling abnormal—Carmustine—lymphatic system cancer	0.000218	0.00204	CcSEcCtD
Pentoxifylline—Asthenia—Bleomycin—lymphatic system cancer	0.000217	0.00203	CcSEcCtD
Pentoxifylline—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000216	0.00203	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000216	0.00202	CcSEcCtD
Pentoxifylline—Constipation—Vincristine—lymphatic system cancer	0.000216	0.00202	CcSEcCtD
Pentoxifylline—Pruritus—Bleomycin—lymphatic system cancer	0.000214	0.00201	CcSEcCtD
Pentoxifylline—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000213	0.002	CcSEcCtD
Pentoxifylline—Constipation—Mitoxantrone—lymphatic system cancer	0.00021	0.00197	CcSEcCtD
Pentoxifylline—Body temperature increased—Carmustine—lymphatic system cancer	0.000209	0.00196	CcSEcCtD
Pentoxifylline—Abdominal pain—Carmustine—lymphatic system cancer	0.000209	0.00196	CcSEcCtD
Pentoxifylline—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000206	0.00193	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000206	0.00193	CcSEcCtD
Pentoxifylline—Pancytopenia—Methotrexate—lymphatic system cancer	0.000204	0.00191	CcSEcCtD
Pentoxifylline—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000202	0.0019	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000201	0.00188	CcSEcCtD
Pentoxifylline—Abdominal pain—Vincristine—lymphatic system cancer	0.000199	0.00187	CcSEcCtD
Pentoxifylline—Body temperature increased—Vincristine—lymphatic system cancer	0.000199	0.00187	CcSEcCtD
Pentoxifylline—Urticaria—Mitoxantrone—lymphatic system cancer	0.000195	0.00183	CcSEcCtD
Pentoxifylline—Hypersensitivity—Carmustine—lymphatic system cancer	0.000195	0.00182	CcSEcCtD
Pentoxifylline—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000194	0.00182	CcSEcCtD
Pentoxifylline—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000194	0.00182	CcSEcCtD
Pentoxifylline—Vomiting—Bleomycin—lymphatic system cancer	0.000192	0.0018	CcSEcCtD
Pentoxifylline—Drowsiness—Methotrexate—lymphatic system cancer	0.000192	0.0018	CcSEcCtD
Pentoxifylline—Infestation—Methotrexate—lymphatic system cancer	0.000192	0.0018	CcSEcCtD
Pentoxifylline—Infestation NOS—Methotrexate—lymphatic system cancer	0.000192	0.0018	CcSEcCtD
Pentoxifylline—Rash—Bleomycin—lymphatic system cancer	0.000191	0.00179	CcSEcCtD
Pentoxifylline—Dermatitis—Bleomycin—lymphatic system cancer	0.000191	0.00179	CcSEcCtD
Pentoxifylline—Asthenia—Carmustine—lymphatic system cancer	0.000189	0.00178	CcSEcCtD
Pentoxifylline—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000186	0.00175	CcSEcCtD
Pentoxifylline—Hypersensitivity—Vincristine—lymphatic system cancer	0.000186	0.00174	CcSEcCtD
Pentoxifylline—Sweating—Methotrexate—lymphatic system cancer	0.000184	0.00172	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000181	0.0017	CcSEcCtD
Pentoxifylline—Epistaxis—Methotrexate—lymphatic system cancer	0.000181	0.0017	CcSEcCtD
Pentoxifylline—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000181	0.0017	CcSEcCtD
Pentoxifylline—Asthenia—Vincristine—lymphatic system cancer	0.000181	0.0017	CcSEcCtD
Pentoxifylline—Diarrhoea—Carmustine—lymphatic system cancer	0.000181	0.00169	CcSEcCtD
Pentoxifylline—Nausea—Bleomycin—lymphatic system cancer	0.00018	0.00168	CcSEcCtD
Pentoxifylline—Asthenia—Mitoxantrone—lymphatic system cancer	0.000176	0.00165	CcSEcCtD
Pentoxifylline—Dizziness—Carmustine—lymphatic system cancer	0.000175	0.00164	CcSEcCtD
Pentoxifylline—Haemoglobin—Methotrexate—lymphatic system cancer	0.000173	0.00162	CcSEcCtD
Pentoxifylline—Diarrhoea—Vincristine—lymphatic system cancer	0.000172	0.00162	CcSEcCtD
Pentoxifylline—Haemorrhage—Methotrexate—lymphatic system cancer	0.000172	0.00161	CcSEcCtD
Pentoxifylline—Hepatitis—Methotrexate—lymphatic system cancer	0.000172	0.00161	CcSEcCtD
Pentoxifylline—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000168	0.00157	CcSEcCtD
Pentoxifylline—Vomiting—Carmustine—lymphatic system cancer	0.000168	0.00157	CcSEcCtD
Pentoxifylline—Dizziness—Vincristine—lymphatic system cancer	0.000167	0.00156	CcSEcCtD
Pentoxifylline—Rash—Carmustine—lymphatic system cancer	0.000166	0.00156	CcSEcCtD
Pentoxifylline—Dermatitis—Carmustine—lymphatic system cancer	0.000166	0.00156	CcSEcCtD
Pentoxifylline—Headache—Carmustine—lymphatic system cancer	0.000165	0.00155	CcSEcCtD
Pentoxifylline—Vomiting—Vincristine—lymphatic system cancer	0.00016	0.0015	CcSEcCtD
Pentoxifylline—Rash—Vincristine—lymphatic system cancer	0.000159	0.00149	CcSEcCtD
Pentoxifylline—Dermatitis—Vincristine—lymphatic system cancer	0.000159	0.00149	CcSEcCtD
Pentoxifylline—Headache—Vincristine—lymphatic system cancer	0.000158	0.00148	CcSEcCtD
Pentoxifylline—Nausea—Carmustine—lymphatic system cancer	0.000157	0.00147	CcSEcCtD
Pentoxifylline—Vomiting—Mitoxantrone—lymphatic system cancer	0.000156	0.00146	CcSEcCtD
Pentoxifylline—Immune system disorder—Methotrexate—lymphatic system cancer	0.000155	0.00146	CcSEcCtD
Pentoxifylline—Rash—Mitoxantrone—lymphatic system cancer	0.000155	0.00145	CcSEcCtD
Pentoxifylline—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000155	0.00145	CcSEcCtD
Pentoxifylline—Headache—Mitoxantrone—lymphatic system cancer	0.000154	0.00144	CcSEcCtD
Pentoxifylline—Erythema—Methotrexate—lymphatic system cancer	0.00015	0.0014	CcSEcCtD
Pentoxifylline—Nausea—Vincristine—lymphatic system cancer	0.00015	0.0014	CcSEcCtD
Pentoxifylline—Dysgeusia—Methotrexate—lymphatic system cancer	0.000147	0.00138	CcSEcCtD
Pentoxifylline—Nausea—Mitoxantrone—lymphatic system cancer	0.000146	0.00137	CcSEcCtD
Pentoxifylline—Back pain—Methotrexate—lymphatic system cancer	0.000145	0.00136	CcSEcCtD
Pentoxifylline—Vision blurred—Methotrexate—lymphatic system cancer	0.000141	0.00132	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000139	0.0013	CcSEcCtD
Pentoxifylline—Anaemia—Methotrexate—lymphatic system cancer	0.000138	0.0013	CcSEcCtD
Pentoxifylline—Malaise—Methotrexate—lymphatic system cancer	0.000135	0.00127	CcSEcCtD
Pentoxifylline—Leukopenia—Methotrexate—lymphatic system cancer	0.000134	0.00126	CcSEcCtD
Pentoxifylline—Convulsion—Methotrexate—lymphatic system cancer	0.00013	0.00122	CcSEcCtD
Pentoxifylline—Chest pain—Methotrexate—lymphatic system cancer	0.000128	0.0012	CcSEcCtD
Pentoxifylline—Myalgia—Methotrexate—lymphatic system cancer	0.000128	0.0012	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000127	0.00119	CcSEcCtD
Pentoxifylline—Discomfort—Methotrexate—lymphatic system cancer	0.000126	0.00118	CcSEcCtD
Pentoxifylline—Confusional state—Methotrexate—lymphatic system cancer	0.000123	0.00116	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000122	0.00115	CcSEcCtD
Pentoxifylline—Infection—Methotrexate—lymphatic system cancer	0.000121	0.00114	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.00012	0.00112	CcSEcCtD
Pentoxifylline—Skin disorder—Methotrexate—lymphatic system cancer	0.000119	0.00111	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000118	0.00111	CcSEcCtD
Pentoxifylline—Anorexia—Methotrexate—lymphatic system cancer	0.000117	0.00109	CcSEcCtD
Pentoxifylline—Hypotension—Methotrexate—lymphatic system cancer	0.000114	0.00107	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000111	0.00104	CcSEcCtD
Pentoxifylline—Insomnia—Methotrexate—lymphatic system cancer	0.000111	0.00104	CcSEcCtD
Pentoxifylline—Dyspnoea—Methotrexate—lymphatic system cancer	0.000109	0.00102	CcSEcCtD
Pentoxifylline—Somnolence—Methotrexate—lymphatic system cancer	0.000109	0.00102	CcSEcCtD
Pentoxifylline—Dyspepsia—Methotrexate—lymphatic system cancer	0.000108	0.00101	CcSEcCtD
Pentoxifylline—Decreased appetite—Methotrexate—lymphatic system cancer	0.000106	0.000997	CcSEcCtD
Pentoxifylline—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000101	0.000945	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.0001	0.000938	CcSEcCtD
Pentoxifylline—Urticaria—Methotrexate—lymphatic system cancer	9.72e-05	0.000911	CcSEcCtD
Pentoxifylline—Abdominal pain—Methotrexate—lymphatic system cancer	9.67e-05	0.000906	CcSEcCtD
Pentoxifylline—Body temperature increased—Methotrexate—lymphatic system cancer	9.67e-05	0.000906	CcSEcCtD
Pentoxifylline—Hypersensitivity—Methotrexate—lymphatic system cancer	9.01e-05	0.000845	CcSEcCtD
Pentoxifylline—Asthenia—Methotrexate—lymphatic system cancer	8.77e-05	0.000823	CcSEcCtD
Pentoxifylline—Pruritus—Methotrexate—lymphatic system cancer	8.65e-05	0.000811	CcSEcCtD
Pentoxifylline—Diarrhoea—Methotrexate—lymphatic system cancer	8.37e-05	0.000784	CcSEcCtD
Pentoxifylline—Dizziness—Methotrexate—lymphatic system cancer	8.09e-05	0.000758	CcSEcCtD
Pentoxifylline—Vomiting—Methotrexate—lymphatic system cancer	7.78e-05	0.000729	CcSEcCtD
Pentoxifylline—Rash—Methotrexate—lymphatic system cancer	7.71e-05	0.000723	CcSEcCtD
Pentoxifylline—Dermatitis—Methotrexate—lymphatic system cancer	7.7e-05	0.000722	CcSEcCtD
Pentoxifylline—Headache—Methotrexate—lymphatic system cancer	7.66e-05	0.000718	CcSEcCtD
Pentoxifylline—Nausea—Methotrexate—lymphatic system cancer	7.26e-05	0.000681	CcSEcCtD
